Annual CAPEX
$3.78 B
+$1.21 B+46.95%
31 December 2023
Summary:
AstraZeneca annual capital expenditures is currently $3.78 billion, with the most recent change of +$1.21 billion (+46.95%) on 31 December 2023. During the last 3 years, it has risen by +$1.17 billion (+44.97%). AZN annual CAPEX is now -18.21% below its all-time high of $4.62 billion, reached on 31 December 2012.AZN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$1.36 B
+$690.00 M+103.29%
30 September 2024
Summary:
AstraZeneca quarterly capital expenditures is currently $1.36 billion, with the most recent change of +$690.00 million (+103.29%) on 30 September 2024. Over the past year, it has increased by +$479.00 million (+54.49%). AZN quarterly CAPEX is now -61.98% below its all-time high of $3.57 billion, reached on 30 September 2012.AZN Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$4.58 B
+$479.00 M+11.69%
30 September 2024
Summary:
AstraZeneca TTM capital expenditures is currently $4.58 billion, with the most recent change of +$479.00 million (+11.69%) on 30 September 2024. Over the past year, it has increased by +$1.19 billion (+35.17%). AZN TTM CAPEX is now -7.24% below its all-time high of $4.93 billion, reached on 30 June 2013.AZN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.0% | +54.5% | +35.2% |
| 3 y3 years | +45.0% | +105.8% | +125.5% |
| 5 y5 years | +175.6% | +298.2% | +84.3% |
AZN CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +71.7% | -15.4% | +274.1% | at high | +125.5% |
| 5 y | 5 years | at high | +175.6% | -15.4% | +298.2% | at high | +125.5% |
| alltime | all time | -18.2% | +880.1% | -62.0% | +301.2% | -7.2% |
AstraZeneca CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.36 B(+103.3%) | $4.58 B(+11.7%) |
| June 2024 | - | $668.00 M(-58.4%) | $4.10 B(+4.7%) |
| Mar 2024 | - | $1.60 B(+69.7%) | $3.91 B(+3.6%) |
| Dec 2023 | $3.78 B(+46.9%) | $946.00 M(+7.6%) | $3.78 B(+11.6%) |
| Sept 2023 | - | $879.00 M(+82.0%) | $3.39 B(-6.4%) |
| June 2023 | - | $483.00 M(-67.1%) | $3.62 B(-1.6%) |
| Mar 2023 | - | $1.47 B(+165.3%) | $3.68 B(+43.1%) |
| Dec 2022 | $2.57 B(+16.9%) | $554.00 M(-50.1%) | $2.57 B(-6.0%) |
| Sept 2022 | - | $1.11 B(+104.6%) | $2.73 B(+19.7%) |
| June 2022 | - | $543.00 M(+49.6%) | $2.28 B(+9.1%) |
| Mar 2022 | - | $363.00 M(-49.4%) | $2.09 B(-4.8%) |
| Dec 2021 | $2.20 B(-15.6%) | $718.00 M(+8.8%) | $2.20 B(+8.4%) |
| Sept 2021 | - | $660.00 M(+87.0%) | $2.03 B(-2.2%) |
| June 2021 | - | $353.00 M(-24.7%) | $2.08 B(-23.1%) |
| Mar 2021 | - | $469.00 M(-14.4%) | $2.70 B(+3.6%) |
| Dec 2020 | $2.61 B(+5.9%) | $548.00 M(-22.3%) | $2.61 B(+6.7%) |
| Sept 2020 | - | $705.00 M(-27.8%) | $2.44 B(+17.5%) |
| June 2020 | - | $977.00 M(+159.8%) | $2.08 B(+0.1%) |
| Mar 2020 | - | $376.00 M(-2.3%) | $2.08 B(-15.6%) |
| Dec 2019 | $2.46 B(+79.4%) | $385.00 M(+12.9%) | $2.46 B(-1.0%) |
| Sept 2019 | - | $341.00 M(-65.0%) | $2.48 B(+3.0%) |
| June 2019 | - | $974.00 M(+28.2%) | $2.41 B(+34.2%) |
| Mar 2019 | - | $760.00 M(+85.8%) | $1.80 B(+31.1%) |
| Dec 2018 | $1.37 B(-15.4%) | $409.00 M(+52.0%) | $1.37 B(-9.4%) |
| Sept 2018 | - | $269.00 M(-25.1%) | $1.51 B(-5.3%) |
| June 2018 | - | $359.00 M(+7.5%) | $1.60 B(+1.8%) |
| Mar 2018 | - | $334.00 M(-39.4%) | $1.57 B(-3.1%) |
| Dec 2017 | $1.62 B(-30.0%) | $551.00 M(+56.1%) | $1.62 B(-5.3%) |
| Sept 2017 | - | $353.00 M(+6.6%) | $1.71 B(-0.8%) |
| June 2017 | - | $331.00 M(-14.0%) | $1.72 B(-28.0%) |
| Mar 2017 | - | $385.00 M(-39.9%) | $2.39 B(+3.4%) |
| Dec 2016 | $2.31 B(-17.0%) | $641.00 M(+75.1%) | $2.31 B(+4.8%) |
| Sept 2016 | - | $366.00 M(-63.4%) | $2.21 B(-7.1%) |
| June 2016 | - | $1.00 B(+227.1%) | $2.38 B(+17.7%) |
| Mar 2016 | - | $306.00 M(-42.8%) | $2.02 B(-27.6%) |
| Dec 2015 | $2.79 B(+1.3%) | $535.00 M(+0.2%) | $2.79 B(+2.4%) |
| Sept 2015 | - | $534.00 M(-17.1%) | $2.72 B(+4.6%) |
| June 2015 | - | $644.00 M(-40.1%) | $2.60 B(-16.0%) |
| Mar 2015 | - | $1.07 B(+129.2%) | $3.10 B(+12.6%) |
| Dec 2014 | $2.75 B(+33.7%) | $469.00 M(+13.0%) | $2.75 B(-10.3%) |
| Sept 2014 | - | $415.00 M(-63.6%) | $3.07 B(-1.9%) |
| June 2014 | - | $1.14 B(+56.6%) | $3.13 B(+31.9%) |
| Mar 2014 | - | $728.00 M(-7.4%) | $2.37 B(+15.3%) |
| Dec 2013 | $2.06 B(-55.4%) | $786.00 M(+65.8%) | $2.06 B(+12.1%) |
| Sept 2013 | - | $474.00 M(+23.4%) | $1.84 B(-62.8%) |
| June 2013 | - | $384.00 M(-7.2%) | $4.93 B(+2.1%) |
| Mar 2013 | - | $414.00 M(-26.6%) | $4.83 B(+4.6%) |
| Dec 2012 | $4.62 B(+256.1%) | $564.00 M(-84.2%) | $4.62 B(+4.2%) |
| Sept 2012 | - | $3.57 B(+1171.2%) | $4.43 B(+301.2%) |
| June 2012 | - | $281.00 M(+39.1%) | $1.10 B(-10.0%) |
| Mar 2012 | - | $202.00 M(-46.6%) | $1.23 B(-5.3%) |
| Dec 2011 | $1.30 B | $378.00 M(+54.9%) | $1.30 B(-6.4%) |
| Sept 2011 | - | $244.00 M(-39.6%) | $1.39 B(+1.1%) |
| June 2011 | - | $404.00 M(+49.1%) | $1.37 B(-5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $271.00 M(-42.0%) | $1.45 B(-33.6%) |
| Dec 2010 | $2.18 B(+37.5%) | $467.00 M(+103.9%) | $2.18 B(-5.2%) |
| Sept 2010 | - | $229.00 M(-52.5%) | $2.30 B(-9.0%) |
| June 2010 | - | $482.00 M(-51.9%) | $2.53 B(+9.6%) |
| Mar 2010 | - | $1.00 B(+71.2%) | $2.31 B(+45.3%) |
| Dec 2009 | $1.59 B(-60.7%) | $586.00 M(+28.5%) | $1.59 B(+6.2%) |
| Sept 2009 | - | $456.00 M(+75.4%) | $1.49 B(+11.6%) |
| June 2009 | - | $260.00 M(-8.5%) | $1.34 B(-3.4%) |
| Mar 2009 | - | $284.00 M(-42.4%) | $1.39 B(-65.7%) |
| Dec 2008 | $4.04 B(+140.6%) | $493.00 M(+63.8%) | $4.04 B(+0.5%) |
| Sept 2008 | - | $301.00 M(-2.0%) | $4.02 B(-3.6%) |
| June 2008 | - | $307.00 M(-89.6%) | $4.17 B(-1.0%) |
| Mar 2008 | - | $2.94 B(+523.8%) | $4.21 B(+150.9%) |
| Dec 2007 | $1.68 B(+25.4%) | $471.00 M(+4.0%) | $1.68 B(+12.5%) |
| Sept 2007 | - | $453.00 M(+29.4%) | $1.49 B(+7.4%) |
| June 2007 | - | $350.00 M(-13.6%) | $1.39 B(-11.1%) |
| Mar 2007 | - | $405.00 M(+42.1%) | $1.56 B(+16.7%) |
| Dec 2006 | $1.34 B(+65.3%) | $285.00 M(-18.6%) | $1.34 B(+17.4%) |
| Sept 2006 | - | $350.00 M(-33.1%) | $1.14 B(+7.1%) |
| June 2006 | - | $523.00 M(+189.0%) | $1.06 B(+40.3%) |
| Mar 2006 | - | $181.00 M(+108.0%) | $759.00 M(-6.3%) |
| Dec 2005 | $810.00 M(-23.8%) | $87.00 M(-68.2%) | $810.00 M(-15.0%) |
| Sept 2005 | - | $274.00 M(+26.3%) | $953.00 M(+2.6%) |
| June 2005 | - | $217.00 M(-6.5%) | $929.00 M(-27.7%) |
| Mar 2005 | - | $232.00 M(+0.9%) | $1.28 B(+20.9%) |
| Dec 2004 | $1.06 B(-17.1%) | $230.00 M(-8.0%) | $1.06 B(-49.7%) |
| Sept 2004 | - | $250.00 M(-56.4%) | $2.12 B(+77.7%) |
| June 2004 | - | $573.00 M(+5630.0%) | $1.19 B(-7.9%) |
| Mar 2004 | - | $10.00 M(-99.2%) | $1.29 B(+0.8%) |
| Dec 2003 | $1.28 B(-4.3%) | $1.28 B(-290.0%) | $1.28 B(-4.3%) |
| Sept 2003 | - | -$674.88 M(-200.0%) | $1.34 B(-3.1%) |
| June 2003 | - | $674.88 M(-49.6%) | $1.38 B(+3.2%) |
| Dec 2002 | $1.34 B(-3.2%) | $1.34 B(-312.0%) | $1.34 B(+239.2%) |
| Sept 2002 | - | -$632.00 M(-282.1%) | $395.00 M(-71.6%) |
| June 2002 | - | $347.00 M(+21.8%) | $1.39 B(+4.7%) |
| Mar 2002 | - | $285.00 M(-27.8%) | $1.33 B(-4.3%) |
| Dec 2001 | $1.39 B(-5.2%) | $395.00 M(+9.1%) | $1.39 B(-43.5%) |
| Sept 2001 | - | $362.00 M(+27.4%) | $2.45 B(+68.7%) |
| June 2001 | - | $284.12 M(-17.4%) | $1.45 B(-3.8%) |
| Mar 2001 | - | $343.88 M(-76.5%) | $1.51 B(+3.4%) |
| Dec 2000 | $1.46 B(-2.0%) | $1.46 B(-329.6%) | $1.46 B(>+9900.0%) |
| Sept 2000 | - | -$636.08 M(-286.3%) | $0.00(-100.0%) |
| June 2000 | - | $341.46 M(+15.9%) | $636.08 M(+115.9%) |
| Mar 2000 | - | $294.62 M | $294.62 M |
| Dec 1999 | $1.49 B(+7.0%) | - | - |
| Dec 1998 | $1.39 B(+84.3%) | - | - |
| Dec 1997 | $755.47 M(+18.3%) | - | - |
| Dec 1996 | $638.76 M(+48.2%) | - | - |
| Dec 1995 | $431.11 M(-12.5%) | - | - |
| Dec 1994 | $492.47 M(+6.4%) | - | - |
| Dec 1993 | $462.99 M(+13.9%) | - | - |
| Dec 1992 | $406.47 M(+5.5%) | - | - |
| Dec 1991 | $385.46 M(-28.6%) | - | - |
| Dec 1990 | $540.10 M | - | - |
FAQ
- What is AstraZeneca annual capital expenditures?
- What is the all time high annual CAPEX for AstraZeneca?
- What is AstraZeneca annual CAPEX year-on-year change?
- What is AstraZeneca quarterly capital expenditures?
- What is the all time high quarterly CAPEX for AstraZeneca?
- What is AstraZeneca quarterly CAPEX year-on-year change?
- What is AstraZeneca TTM capital expenditures?
- What is the all time high TTM CAPEX for AstraZeneca?
- What is AstraZeneca TTM CAPEX year-on-year change?
What is AstraZeneca annual capital expenditures?
The current annual CAPEX of AZN is $3.78 B
What is the all time high annual CAPEX for AstraZeneca?
AstraZeneca all-time high annual capital expenditures is $4.62 B
What is AstraZeneca annual CAPEX year-on-year change?
Over the past year, AZN annual capital expenditures has changed by +$1.21 B (+46.95%)
What is AstraZeneca quarterly capital expenditures?
The current quarterly CAPEX of AZN is $1.36 B
What is the all time high quarterly CAPEX for AstraZeneca?
AstraZeneca all-time high quarterly capital expenditures is $3.57 B
What is AstraZeneca quarterly CAPEX year-on-year change?
Over the past year, AZN quarterly capital expenditures has changed by +$479.00 M (+54.49%)
What is AstraZeneca TTM capital expenditures?
The current TTM CAPEX of AZN is $4.58 B
What is the all time high TTM CAPEX for AstraZeneca?
AstraZeneca all-time high TTM capital expenditures is $4.93 B
What is AstraZeneca TTM CAPEX year-on-year change?
Over the past year, AZN TTM capital expenditures has changed by +$1.19 B (+35.17%)